v3.26.1
SEGMENT INFORMATION - Profitability (Details)
$ in Millions
3 Months Ended 6 Months Ended
Apr. 30, 2026
USD ($)
Reportable_segment
Apr. 30, 2025
USD ($)
Reportable_segment
Apr. 30, 2026
USD ($)
Reportable_segment
Apr. 30, 2025
USD ($)
Reportable_segment
Segment Reporting Information        
Number of Reportable Segments | Reportable_segment 3 3 3 3
Segment Reporting Information        
Net revenue $ 1,835 $ 1,668 $ 3,633 $ 3,349
Cost of revenue 845 802 1,697 1,584
Research and Development Expense 126 112 243 225
Selling, General and Administrative Expense 465 454 941 864
Income from operations 399 300 752 676
Share-based compensation expense 34 30 75 71
Operating Segments        
Segment Reporting Information        
Income from operations 483 419 925 841
Life Sciences and Diagnostics Markets        
Segment Reporting Information        
Net revenue 732 654 1,411 1,301
Life Sciences and Diagnostics Markets | Operating Segments        
Segment Reporting Information        
Net revenue 732 654 1,411 1,301
Cost of revenue 337 309 673 614
Research and Development Expense 64 59 129 122
Selling, General and Administrative Expense 170 157 339 319
Income from operations 161 129 270 246
Share-based compensation expense 11 9 25 24
Depreciation 26 24 52 47
Agilent CrossLab        
Segment Reporting Information        
Net revenue 759 713 1,517 1,409
Agilent CrossLab | Operating Segments        
Segment Reporting Information        
Net revenue 759 713 1,517 1,409
Cost of revenue 338 317 678 623
Research and Development Expense 28 27 56 53
Selling, General and Administrative Expense 151 138 301 281
Income from operations 242 231 482 452
Share-based compensation expense 12 11 28 27
Depreciation 14 14 28 28
Applied Markets        
Segment Reporting Information        
Net revenue 344 301 705 639
Applied Markets | Operating Segments        
Segment Reporting Information        
Net revenue 344 301 705 639
Cost of revenue 152 140 309 290
Research and Development Expense 24 23 48 46
Selling, General and Administrative Expense 88 79 175 160
Income from operations 80 59 173 143
Share-based compensation expense 6 5 13 13
Depreciation $ 7 $ 6 $ 13 $ 12